Population Pharmacokinetic Modeling of Total and Free Ceftriaxone in Critically Ill Children and Young Adults and Monte Carlo Simulations Support Twice Daily Dosing for Target Attainment
- 18 January 2022
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 66 (1) , e0142721
Abstract
Critical illness, including sepsis, causes significant pathophysiologic changes that alter the pharmacokinetics (PK) of antibiotics. Ceftriaxone is one of the most prescribed antibiotics in patients admitted to the pediatric intensive care unit (PICU).Keywords
Funding Information
- HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (5T32HD069054-09)
- HHS | NIH | National Center for Advancing Translational Sciences (FUL1TR001425)
- Cincinnati Children's Hospital Medical Center (Anrold W. Strauss Fellow Award)
- Cincinnati Children's Hospital Medical Center (Hospital Medicine Fellow Award)
- Gerber Foundation (Novice Research Award)
This publication has 35 references indexed in Scilit:
- Paediatric Index of Mortality 3Pediatric Critical Care Medicine, 2013
- Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic ReviewAnnals of Intensive Care, 2012
- Population pharmacokinetics of ceftriaxone in critically ill septic patients: a reappraisalBritish Journal of Clinical Pharmacology, 2011
- Tips and traps analyzing pediatric PK dataPediatric Anesthesia, 2011
- Indications for a ceftriaxone dosing regimen in Japanese paediatric patients using population pharmacokinetic/pharmacodynamic analysis and simulationJournal of Pharmacy and Pharmacology, 2011
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Correlation of the MIC and Dose/MIC Ratio of Fluconazole to the Therapeutic Response of Patients with Mucosal Candidiasis and CandidemiaAntimicrobial Agents and Chemotherapy, 2007
- Concentration-Effect Relationship of Ceftazidime Explains Why the Time above the MIC Is 40 Percent for a Static Effect In VivoAntimicrobial Agents and Chemotherapy, 2007
- Use of Monte Carlo Simulations To Select Therapeutic Doses and Provisional Breakpoints of BAL9141Antimicrobial Agents and Chemotherapy, 2004
- Plasma protein binding of ceftriaxoneXenobiotica, 1987